BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26857698)

  • 21. Integrated Bioinformatics and Validation Reveal Potential Biomarkers Associated With Progression of Primary Sjögren's Syndrome.
    Li N; Li L; Wu M; Li Y; Yang J; Wu Y; Xu H; Luo D; Gao Y; Fei X; Jiang L
    Front Immunol; 2021; 12():697157. PubMed ID: 34367157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of differentially expressed genes in primary Sjögren's syndrome.
    Zhang L; Xu P; Wang X; Zhang Z; Zhao W; Li Z; Yang G; Liu P
    J Cell Biochem; 2019 Oct; 120(10):17368-17377. PubMed ID: 31125139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.
    Gottenberg JE; Cagnard N; Lucchesi C; Letourneur F; Mistou S; Lazure T; Jacques S; Ba N; Ittah M; Lepajolec C; Labetoulle M; Ardizzone M; Sibilia J; Fournier C; Chiocchia G; Mariette X
    Proc Natl Acad Sci U S A; 2006 Feb; 103(8):2770-5. PubMed ID: 16477017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells.
    Ha YJ; Choi YS; Kang EH; Chung JH; Cha S; Song YW; Lee YJ
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):31-40. PubMed ID: 28421993
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TBK1: A key regulator and potential treatment target for interferon positive Sjögren's syndrome, systemic lupus erythematosus and systemic sclerosis.
    Bodewes ILA; Huijser E; van Helden-Meeuwsen CG; Tas L; Huizinga R; Dalm VASH; van Hagen PM; Groot N; Kamphuis S; van Daele PLA; Versnel MA
    J Autoimmun; 2018 Jul; 91():97-102. PubMed ID: 29673738
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypomethylation mediates genetic association with the major histocompatibility complex genes in Sjögren's syndrome.
    Chi C; Taylor KE; Quach H; Quach D; Criswell LA; Barcellos LF
    PLoS One; 2021; 16(4):e0248429. PubMed ID: 33886574
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Invariant NKT cells are expanded in peripheral blood but are undetectable in salivary glands of patients with primary Sjögren's syndrome.
    Guggino G; Ciccia F; Raimondo S; Giardina G; Alessandro R; Dieli F; Sireci G; Triolo G
    Clin Exp Rheumatol; 2016; 34(1):25-31. PubMed ID: 26633038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetics and epigenetics in primary Sjögren's syndrome.
    Imgenberg-Kreuz J; Rasmussen A; Sivils K; Nordmark G
    Rheumatology (Oxford); 2021 May; 60(5):2085-2098. PubMed ID: 30770922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetic modifications in salivary glands from patients with Sjögren's syndrome affect cytokeratin 19 expression.
    Konsta OD; Charras A; Le Dantec C; Kapsogeorgeou E; Bordron A; Brooks WH; Tzioufas AG; Pers JO; Renaudineau Y
    Bull Group Int Rech Sci Stomatol Odontol; 2016 Jun; 53(1):e01. PubMed ID: 27352422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a Sjögren's syndrome susceptibility locus at OAS1 that influences isoform switching, protein expression, and responsiveness to type I interferons.
    Li H; Reksten TR; Ice JA; Kelly JA; Adrianto I; Rasmussen A; Wang S; He B; Grundahl KM; Glenn SB; Miceli-Richard C; Bowman S; Lester S; Eriksson P; Eloranta ML; Brun JG; Gøransson LG; Harboe E; Guthridge JM; Kaufman KM; Kvarnström M; Cunninghame Graham DS; Patel K; Adler AJ; Farris AD; Brennan MT; Chodosh J; Gopalakrishnan R; Weisman MH; Venuturupalli S; Wallace DJ; Hefner KS; Houston GD; Huang AJW; Hughes PJ; Lewis DM; Radfar L; Vista ES; Edgar CE; Rohrer MD; Stone DU; Vyse TJ; Harley JB; Gaffney PM; James JA; Turner S; Alevizos I; Anaya JM; Rhodus NL; Segal BM; Montgomery CG; Scofield RH; Kovats S; Mariette X; Rönnblom L; Witte T; Rischmueller M; Wahren-Herlenius M; Omdal R; Jonsson R; Ng WF; ; Nordmark G; Lessard CJ; Sivils KL
    PLoS Genet; 2017 Jun; 13(6):e1006820. PubMed ID: 28640813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Down-regulation of increased TRAF6 expression in the peripheral mononuclear cells of patients with primary Sjögren's syndrome by an EBV-EBER1-specific synthetic single-stranded complementary DNA molecule.
    Sipka S; Zilahi E; Papp G; Chen JQ; Nagy A; Hegyi K; Kónya J; Zeher M
    Int J Rheum Dis; 2017 May; 20(5):614-621. PubMed ID: 28470929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren's syndrome.
    Notarstefano C; Croia C; Pontarini E; Lucchesi D; Sutcliffe N; Tappuni A; Donati V; Pitzalis C; Baldini C; Bombardieri M
    Clin Exp Rheumatol; 2018; 36 Suppl 112(3):145-149. PubMed ID: 30156540
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-36α axis is modulated in patients with primary Sjögren's syndrome.
    Ciccia F; Accardo-Palumbo A; Alessandro R; Alessandri C; Priori R; Guggino G; Raimondo S; Carubbi F; Valesini G; Giacomelli R; Rizzo A; Triolo G
    Clin Exp Immunol; 2015 Aug; 181(2):230-8. PubMed ID: 25902739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of Ro/SSA 60 kDa and La/SSB, but not Ro/SSA 52 kDa, mRNA and protein in minor salivary glands from patients with primary Sjögren's syndrome.
    Barcellos KS; Nonogaki S; Enokihara MM; Teixeira MS; Andrade LE
    J Rheumatol; 2007 Jun; 34(6):1283-92. PubMed ID: 17552056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcription profiling of peripheral B cells in antibody-positive primary Sjögren's syndrome reveals upregulated expression of CX3CR1 and a type I and type II interferon signature.
    Imgenberg-Kreuz J; Sandling JK; Björk A; Nordlund J; Kvarnström M; Eloranta ML; Rönnblom L; Wahren-Herlenius M; Syvänen AC; Nordmark G
    Scand J Immunol; 2018 May; 87(5):e12662. PubMed ID: 29655283
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome.
    Yin H; Zhao M; Wu X; Gao F; Luo Y; Ma L; Liu S; Zhang G; Chen J; Li F; Zuo X; Lu Q
    J Dermatol Sci; 2010 Sep; 59(3):198-203. PubMed ID: 20724115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ductal cells of minor salivary glands in Sjögren's syndrome express LINE-1 ORF2p and APOBEC3B.
    Kalogirou EM; Piperi EP; Tosios KI; Tsiambas E; Fanourakis G; Sklavounou A
    J Oral Pathol Med; 2018 Feb; 47(2):179-185. PubMed ID: 29057505
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autoantibodies to La/SSB in patients with primary Sjögren's syndrome (pSS) are associated with upregulation of La/SSB mRNA in minor salivary gland biopsies (MSGs).
    Tzioufas AG; Hantoumi I; Polihronis M; Xanthou G; Moutsopoulos HM
    J Autoimmun; 1999 Dec; 13(4):429-34. PubMed ID: 10585759
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Th1 predominance and perforin expression in minor salivary glands from patients with primary Sjögren's syndrome.
    Kolkowski EC; Reth P; Pelusa F; Bosch J; Pujol-Borrell R; Coll J; Jaraquemada D
    J Autoimmun; 1999 Aug; 13(1):155-62. PubMed ID: 10441181
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of plasmacytoid dendritic cells with B cell infiltration in minor salivary glands in patients with Sjögren's syndrome.
    Zhao J; Kubo S; Nakayamada S; Shimajiri S; Zhang X; Yamaoka K; Tanaka Y
    Mod Rheumatol; 2016 Sep; 26(5):716-24. PubMed ID: 26706891
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.